“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis”. Farmeconomia. Health Economics and Therapeutic Pathways 25, no. 1 (December 17, 2024). Accessed December 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1568.